BPU17, identified by its CAS number 2198977-68-1, is a chemical compound that has garnered attention in various fields, particularly in medicinal chemistry and pharmacology. While specific details about its structure and properties may not be widely documented, compounds like BPU17 are typically characterized by their unique molecular frameworks, which can influence their biological activity and interactions. Such substances often undergo rigorous testing to evaluate their efficacy, safety, and potential therapeutic applications. Characteristics of compounds in this category may include solubility in various solvents, stability under different conditions, and reactivity with other chemical species. Additionally, BPU17 may exhibit specific pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion (ADME), which are crucial for understanding its behavior in biological systems. As research progresses, more detailed information regarding its mechanism of action, potential side effects, and applications in drug development may become available, contributing to the broader understanding of its significance in scientific research.

BPU17

2198977-68-1: BPU17, identified by its CAS number 2198977-68-1, is a chemical compound that has garnered attention in various fields, particularly in medicinal chemistry and pharmacology. While specific details about its structure and properties may not be widely documented, compounds like BPU17 are typically characterized by their unique molecular frameworks, which can influence their biological activity and interactions. Such substances often undergo rigorous testing to evaluate their efficacy, safety, and potential therapeutic applications. Characteristics of compounds in this category may include solubility in various solvents, stability under different conditions, and reactivity with other chemical species. Additionally, BPU17 may exhibit specific pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion (ADME), which are crucial for understanding its behavior in biological systems. As research progresses, more detailed information regarding its mechanism of action, potential side effects, and applications in drug development may become available, contributing to the broader understanding of its significance in scientific research.

<p>BPU17 interacts with PHB1 and disrupts the PHB1-PHB2 interaction, causing slight mitochondrial dysfunction. This damage hinders transcription dependent on SRF/CArG-box, thereby inhibiting epithelial-mesenchymal transition (EMT) in retinal pigment epithelial cells (RPEs). BPU17 has demonstrated anti-fibrotic activity in vivo. It holds potential as a research agent for anti-angiogenic age-related macular degeneration (nAMD).</p>

CAS 2198977-68-1

BPU17

BPU17

Ref: TM-T200681